PNC Financial Services Group’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | -$10 | – | 4735 |
|
|
2023
Q1 | – | Hold |
0
| – | -$30 | – | 4655 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4735 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4443 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4479 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4516 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$22K | – | 4441 |
|
|
2021
Q3 | $22K | Hold |
3
| – | – | ﹤0.01% | 3453 |
|
|
2021
Q2 | $33K | Hold |
3
| – | – | ﹤0.01% | 3265 |
|
|
2021
Q1 | $30K | Hold |
3
| – | – | ﹤0.01% | 3234 |
|
|
2020
Q4 | $26K | Hold |
3
| – | – | ﹤0.01% | 3218 |
|
|
2020
Q3 | $23K | Buy |
+3
| New | +$23K | ﹤0.01% | 3154 |
|